The latest benefit of obesity drugs: boosting testosterone and sperm quality - Nature
A systematic review presented at the Endocrine Society’s annual meeting suggests that GLP-1 obesity drugs may improve testosterone levels and sperm quality in men. While preliminary, the findings indicate a potential secondary health benefit for fertility.
Why it matters
As obesity drugs become widely used, understanding their full range of physiological effects is crucial for long-term patient health and medical guidance.
Mariana Lenharo is a reporter for Nature in New York City.
The article reports on scientific research findings with appropriate caveats regarding the preliminary nature of the data.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in